Richwood Investment Advisors LLC Sells 133 Shares of The Clorox Company (NYSE:CLX)

Richwood Investment Advisors LLC trimmed its position in The Clorox Company (NYSE:CLXFree Report) by 3.3% during the fourth quarter, Holdings Channel reports. The firm owned 3,906 shares of the company’s stock after selling 133 shares during the quarter. Richwood Investment Advisors LLC’s holdings in Clorox were worth $634,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently modified their holdings of CLX. Charles Schwab Investment Management Inc. raised its holdings in Clorox by 1.8% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 723,906 shares of the company’s stock valued at $117,932,000 after acquiring an additional 13,038 shares during the period. Public Employees Retirement System of Ohio raised its holdings in Clorox by 26.3% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 59,766 shares of the company’s stock valued at $9,736,000 after acquiring an additional 12,428 shares during the period. Fifth Third Wealth Advisors LLC bought a new position in Clorox in the 4th quarter valued at about $204,000. Apollon Wealth Management LLC raised its holdings in Clorox by 119.6% in the 4th quarter. Apollon Wealth Management LLC now owns 3,364 shares of the company’s stock valued at $546,000 after acquiring an additional 1,832 shares during the period. Finally, Miracle Mile Advisors LLC bought a new position in Clorox in the 4th quarter valued at about $1,566,000. 78.53% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on CLX shares. StockNews.com lowered shares of Clorox from a “buy” rating to a “hold” rating in a research report on Sunday, January 5th. DA Davidson decreased their target price on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 5th. JPMorgan Chase & Co. increased their target price on shares of Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a research report on Tuesday, February 4th. Evercore ISI increased their target price on shares of Clorox from $145.00 to $155.00 in a research report on Tuesday, February 4th. Finally, Royal Bank of Canada restated a “sector perform” rating and set a $150.00 target price on shares of Clorox in a research report on Thursday, January 30th. Three investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has issued a buy rating to the company. According to MarketBeat.com, Clorox presently has an average rating of “Hold” and a consensus target price of $159.62.

Read Our Latest Analysis on CLX

Clorox Stock Performance

NYSE CLX opened at $144.88 on Friday. The firm has a market capitalization of $17.85 billion, a price-to-earnings ratio of 39.58, a P/E/G ratio of 2.62 and a beta of 0.45. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The firm’s 50 day simple moving average is $152.84 and its 200 day simple moving average is $159.77. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.37.

Clorox (NYSE:CLXGet Free Report) last issued its quarterly earnings data on Monday, February 3rd. The company reported $1.55 EPS for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period in the prior year, the business posted $2.16 earnings per share. As a group, research analysts expect that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be paid a $1.22 dividend. This represents a $4.88 annualized dividend and a yield of 3.37%. The ex-dividend date is Wednesday, April 23rd. Clorox’s payout ratio is 133.33%.

About Clorox

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Further Reading

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.